The Georgian Door standard for peptides in Dublin.

We don't sell peptides, and we won't point you to a shopfront without a verification step first. Our approach: read the Certificate of Analysis for the exact batch before you pay anyone, and confirm it was issued by a laboratory independent of the seller. If you'd like to see the single source we've reviewed against that standard, it sits behind one clearly marked page — everything before that page is educational.

BPC-157 is not authorised as a medicine by the European Medicines Agency or by the HPRA for any human use. It is handled strictly as a laboratory research compound, and nothing here should be read as a route to obtaining it. Where it appears in research documentation, the questions that matter are lot-specific HPLC purity and LC-MS identity confirmation. Our BPC-157 file, behind door No. 1, goes deeper on how to read that paperwork.

Semaglutide is a prescription medicine: obtaining it without a prescription, or through channels that are not authorised, is illegal in Ireland. Research-grade material is a separate category from the medicine dispensed by pharmacies and the two should never be confused. Where research documentation is concerned, the same standard applies as anywhere else: an independent Certificate of Analysis for the specific lot, stating purity and confirming molecular identity. Our semaglutide file sits behind door No. 2.

No. The Georgian Door is an editorial project — we publish research and verification guidance for Dublin-based buyers and researchers. We don't sell products, we don't ask for your email, and we don't provide medical advice. Where we do point to a specific, reviewed source, that link sits on its own clearly labelled page, separate from the guides.

Because Ireland is a jurisdiction where these rules are actively enforced by the HPRA, and because most of the compounds discussed here are not authorised medicines. That shapes what we will and won't publish: we state regulatory status for every substance, and we don't publish availability claims, delivery guidance, sourcing shortcuts or anything else that would read as help obtaining a product. Documentation is the whole subject.

A handful of signals repeat across weak paperwork: a Certificate of Analysis that never changes between batches, no named laboratory or accreditation you can check, no answer to a direct question about lot numbers, and a document that only appears after money has been discussed. Documentation worth trusting is lot-specific, independently issued, and handed over without friction.

Because the questions we hear are specific to this city: how Irish regulation is actually enforced here, what the HPRA's remit means in practice, and which research compounds Dublin-based readers are actually asking about right now — BPC-157, semaglutide and retatrutide, in that order. A generic guide answers none of that precisely; ours is written from Dublin, for the way Dublin buyers actually shop.